Conference Coverage

Hair tracks HIV antiretroviral adherence


 

AT CROI

Meanwhile, self-reported adherence – a median of 100% in each arm – barely correlated with actual ARV levels (Pearson’s r 0.15).

In the end, “hair levels were the strongest independent predictor of how you did,” said lead investigator Monica Gandhi, MD, associate chief of the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco, General Hospital.

Alex Otto/Frontline Medical News

Dr. Monica Ghandi

Testing for hair levels is already a part of clinical care at UCSF, which has a hair analysis lab. In one case, a 21-year-old man seroconverted after saying he was taking pre-exposure prophylaxis (PrEP) perfectly. After a check of his hair, it turned out that he was, but had caught a drug-resistant virus. Another patient who seroconverted on PrEP turned out to have missed some doses a few months before.

Ideally, hair testing could be used early on to provide extra help to patients who prove to have trouble with adherence. Text messaging – as long as the doctor actually responds – is effective, but so is just bringing people in and asking them how they needed to be helped, Dr. Gandhi said.

Recommended Reading

Gene therapy moves from promise to reality
MDedge Family Medicine
Trial seeks improved regimens for pregnant women with HIV
MDedge Family Medicine
nPEP for HIV: Updated CDC guidelines available for primary care physicians
MDedge Family Medicine
FDA approves complete combo tablet for HIV
MDedge Family Medicine
FDA approves new combination drug for HIV patients
MDedge Family Medicine
Gut-homing protein predicts HIV-acquisition, disease progression in women
MDedge Family Medicine
Inflammatory markers predict vaccine response in HCV, HIV
MDedge Family Medicine
VIDEO: The return of Kaposi’s sarcoma
MDedge Family Medicine
Bloating. Flatulence. Think SIBO
MDedge Family Medicine
One-month TB-prevention regimen effective in HIV+ individuals
MDedge Family Medicine